These associations remained consistent across subgroup analyses, including patients using tirzepatide as adjunctive therapy to other first-line diabetes agents, among patients older than 60 and comparisons against individual GLP-1 drugs, including semaglutide and dulaglutide
Risks and Considerations When Using Tirzepatide Possible Side Effects of Tirzepatide Like many medications, tirzepatide can cause side effects
This appeal to youth is intentional
endorsed by international guidelines such as ADA and EASD, to highlight the potential of SGLT2 inhibitors and GLP-1 RAs to improve cardiorenal outcomes for patients with T2D [38, 40]
PlexusDx starts patients on the lowest effective dose to allow gradual adaptation, which often reduces the intensity of early side effects
Semaglutide is not recommended for individuals who: Have a personal or family history of medullary thyroid carcinoma (MTC) Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Have a history of pancreatitis Are pregnant, breastfeeding, or trying to conceive Have a BMI below 27 without weight-related health conditions Dr